Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by CareDx, Inc.

< Previous 1 2 3 Next >
CareDx to Report First Quarter 2024 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Appoints Bryan Riggsbee to Its Board of Directors
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Issues Statement in Patent Infringement Case
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Third Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Third Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces CEO Transition
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx To Present at the 2023 Cantor Global Healthcare Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Second Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Second Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx’s HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Acquires MediGO, an Organ Transplant Supply Chain and Logistics Company
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress
From CareDx, Inc.
Via Business Wire
Tickers CDNA
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.